Breath-enhanced ultrasonic nebulizer and dedicated unit dose ampoule

• US 20050081845A1
• Filed: 08/30/2002
• Published: 04/21/2005
• Est. Priority Date: 09/12/2001
• Status: Active Grant

• Current Assignee: Norton Healthcare Limited (Teva Pharmaceutical Industries Limited)
• Original Assignee: Norton Healthcare Limited (Teva Pharmaceutical Industries Limited)
• Inventors: Striebig, Rachel, O'Leary, David, Chew, Sophia, Barney, Brian, Fairburn, Paul
• Granted Patent: US 7,261,102 B2
• Time in Patent Office: Days
• US Class Current: 128/200.160
• CPC Class Codes: A61M 15/0016 located downstream of the dispenser, i.e. traversed by the product
• CPC Class Codes: A61M 15/0018 with exhalation check valves
• CPC Class Codes: A61M 15/0028 using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
• CPC Class Codes: A61M 15/0033 Details of the piercing or cutting means
• CPC Class Codes: A61M 15/0085 using ultrasonics spraying or atomising liquids using ultrasonic vibrations in general B05B17/06
• CPC Class Codes: A61M 16/208 Non-controlled one-way valves, e.g. exhalation, check, pop-off non-rebreathing valves
• CPC Class Codes: A61M 2205/14 Detection of the presence or absence of a tube, a connector or a container in an apparatus

Abstract

A medicament delivery system comprises a nebulizer device, an open-faced mist chamber-defining element having a tubular input/output port, a tubular inhalation port connecting to the output port of the mist chamber-defining element, and a sealed unit dose ampoule adapted to fit within the mist chamber-defining element. The nebulizer device includes an ultrasonic transducer responsive to applied electrical energy to generate ultrasonic energy, an ultrasonic transmission horn between an input energy surface at an input end and an energy delivery surface at an output end. The sealed unit dose ampoule can be placed directly into the nebulizer device and acts as both the dose cup and baffle, so that the chance of spillage of drug and the number of components to be cleaned are minimized. The unit dose ampoule has a conical base to allow ultrasonic energy conducted from the ultrasonic system to be concentrated at the base of the ampoule. The inhalation port includes an inhalation valve and an exhalation valve.

Claims

1. A medicament delivery system comprising:

A. a nebulizer including a housing extending along a housing axis from a base end to an energy delivery end, said housing including therein;

i. an ultrasonic transducer responsive to applied electrical energy to generate ultrasonic energy at an output surface thereof;

ii. an ultrasonic transmission horn extending along said housing axis between an input energy surface at an input end and an energy delivery surface at an output end, said input energy surface being acoustically coupled to said output surface of said transducer, said horn being adapted to transmit ultrasonic energy applied at said. input energy surface along said housing axis to said energy delivery surface,

B. an open-faced mist chamber-defining element extending along a chamber axis from an open-faced coupling end and said mist chamber-defining element including a tubular input/output port extending therefrom along a port axis, said port axis being angularly offset from said chamber axis,

C. coupling means for selectively coupling said open-faced coupling end of said mist chamber-defining element to said energy delivery end of said housing whereby said interior volume of said mist chamber-defining element is opposite said energy delivery surface of said horn and said chamber axis is substantially parallel to said housing axis,

D. a tubular inhalation port extending between a user end and a device end,

E. a bidirectioinal valve assembly having a first port coupled to said device end of said inhalation port, a second port coupled to said port of said mist chamber-defining element and a third port coupled to points exterior to said bidirectioinal valve assembly, wherein said valve assembly defines a unidirectional airflow path only from said interior volume of said mist chamber-defining element to said user end of said inhalation port when the pneumatic pressure in said inhalation port is lower than the pneumatic pressure in said interior volume of said mist chamber-defining element, and wherein said valve assembly defines a unidirectional airflow path only from said user end of said inhalation port to said exterior points, when the pneumatic pressure in said inhalation port is greater than the pneumatic pressure in said interior volume of said mist chamber-defining element.

2. A medicament delivery system according to claim 1, further comprising:

a cup-shaped medicament ampoule having an open-faced interior region defined by a base member extending from an open top ring at a top end along an ampoule axis to a closed end opposite said top end, wherein said closed end has an outer surface complimentary to said energy delivery surface of said ultrasonic transmission horn, and wherein said ampoule is adapted to fit within said mist chamber-defining element with said outer surface of said closed end of said ampoule fitting in intimate contact with said energy delivery surface of said ultrasonic transmission horn.

3. A medicament delivery system according to claim 2 wherein said ampoule includes a medicament disposed in said interior region of said ampoule and wherein said open top ring of said ampoule is spanned by a sheet member whereby said interior region of said ampoule is closed.

4. A medicament delivery system according to claim 3 wherein said sheet member is removable.

5. A medicament delivery system according to claim 3 wherein said sheet member is frangible.

6. A medicament delivery system according to claim 1 wherein said mist chamber-defining element is dome-shaped.

7. A medicament delivery system according to claim 1 wherein said port axis is offset from said chamber axis by an angle in the-range 35 to 55 degrees.

8. A medicament delivery system according to claim 1 wherein said port axis is offset from said chamber axis by 45 degrees.

9. A medicament delivery system according to claim 1 wherein said energy delivery surface is cone-shaped.

10. A medicament delivery system according to claim 1 wherein said bi-direction valve assembly is a discrete assembly adapted for removable coupling of said second port of said bi-direction valve assembly.

12. A medicament delivery system according to claim 1 wherein said mist chamber-defining element is transparent.

13. A medicament delivery system according to claim 1 wherein said mist chamber-defining element is translucent.

14. A medicament delivery system according to claim 1 wherein said mist chamber-defining element is opaque.

15. A medicament delivery system according to claim 1, further comprising:

A. an ampoule sensors including means for sensing the presence of a medicament ampoule in a predetermined position within said mist chamber-defining element and in response thereto, for generating a control signal representative thereof,

B. means responsive to said control signal to allow electrical energy to be applied to said transducer, and for preventing application of electrical energy otherwise.

11. A medicament delivery system wherein said bi-direction valve assembly is integral with said port of said mist chamber-defining element.